BVF »

X4 Pharmaceuticals shares owned by BVF

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by BVF from 13F filings

Historical chart of BVF investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by BVF

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6M 2.2M 3.42

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cidara Therapeutics Com New (CDTX)
Gh Research Ordinary Shares (GHRS)
Mirum Pharmaceuticals (MIRM)
Xoma Royalty Corporation Com New (XOMA)
Structure Therapeutics Sponsored Ads (GPCR)
Kura Oncology (KURA)
Septerna (SEPN)
Palvella Therapeutics Inc Ne (PVLA)
Nektar Therapeutics Com New (NKTR)
Zymeworks Del (ZYME)
Axsome Therapeutics (AXSM)

View all positions for BVF

Top funds holding X4 Pharmaceuticals

Vanguard Group
Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Boothbay Fund Management
Pale Fire Capital SE
Susquehanna International
Palumbo Wealth Management
Geode Capital Management
Millennium Management

View all funds holding X4 Pharmaceuticals